These children are also recommended to receive 2 doses of 23vPPV:

  • 1st dose at 4 years of age and at a minimum of 2 months after a 13vPCV dose
  • 2nd dose at least 5 years after the 1st 23vPPV dose

This schedule does not apply to people who have had a haematopoietic stem cell transplant. See Table. Recommendations for revaccination after haematopoietic stem cell transplant in children and adults.

Number of 13vPCV doses received previously

Age at presentation

Age at 1st dose of PCV

Age at 2nd dose of PCV

Age at 3rd dose of PCV

Number of further primary PCV dose(s) required

Number of PCV booster doses needed at age ≥12 months

None

<12 months

na

na

na

3

1

12–59 months

na

na

na

1

1

1

<12 months

Any age

na

na

2

1

12–59 months

<12 months

na

na

1

1

≥12 months

na

na

None

1

2

<12 months

Any age

Any age

na

1

1

12–59 months

<12 months

<12 months

na

1

1

12–59 months

<12 months

≥12 months

na

None

1

12–59 months

≥12 months

≥12 months

na

None

None

3

<12 months

Any age

Any age

Any age

None

1

12–59 months

<12 months

<12 months

Any age

None

1

12–59 months

<12 months

≥12 months

≥12 months

None

None

na = not applicable

Last updated: 
3 June 2020
Last reviewed: 
3 June 2020

Definitions

23vPPV
23-valent pneumococcal polysaccharide vaccine
13vPCV
13-valent pneumococcal conjugate vaccine